Scientists have created a prototype test that can predict which drug combinations are likely to work for cancer patients in as little as 24 to 48 hours.
Apr 4, 2022
0
17
A new study led by scientists at The Institute of Cancer Research, London, has changed our understanding of invasive lobular breast cancer—and could increase the number of patients who access new treatments via lobular ...
Mar 30, 2022
0
17
Matching cancer patients to treatment based on their levels of a key immune protein may allow doctors to select those who would benefit most from the combination of immunotherapy and chemotherapy, researchers report.
Mar 28, 2022
0
71
Analyzing cancer DNA in spinal fluid could speed up and improve the diagnosis of breast cancer which has spread to the brain and spinal cord, according to a new pilot study.
Mar 21, 2022
0
21
Cancer cells can become resistant to treatment—it is one of the main reasons treatments, which were successful to start, can then begin to fail. There are different reasons this can happen and Professor James O'Connor, ...
Feb 17, 2022
0
30
Combining targeted, focused ultrasound and immunotherapy drugs could work as a new treatment for pancreatic cancers, a new study has shown.
Feb 7, 2022
0
34
Scientists have revealed how cancer can resist PARP inhibitors, a precision medicine used to treat thousands of patients worldwide.
Jan 11, 2022
0
64
The first cancer patients are to receive doses of an innovative new drug that targets a master regulatory pathway in cells, as part of a new clinical trial.
Jan 3, 2022
0
19
Adding abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death from the disease.
Dec 28, 2021
0
35
In the mid-2000s, the National Cancer Institute (NCI) in the US brought together a group of experts to try to overcome an issue that had arisen in the reporting of results from breast cancer clinical trials.
Dec 7, 2021
0
7
